Cholesterol and Statin Therapy Guide Topical Map: SEO Clusters
Use this Cholesterol and Statin Therapy Guide topical map to cover what do my cholesterol numbers mean with topic clusters, pillar pages, article ideas, content briefs, AI prompts, and publishing order.
Built for SEOs, agencies, bloggers, and content teams that need a practical content plan for Google rankings, AI Overview eligibility, and LLM citation.
1. Understanding Cholesterol and Cardiovascular Risk
Explains what cholesterol is, how to interpret lipid panels, and how cholesterol ties to cardiovascular risk. This foundational group answers common patient questions and supplies the risk frameworks clinicians use to decide treatment.
Complete Guide to Cholesterol Numbers, Lipid Panels, and Cardiovascular Risk
This pillar teaches readers what each lipid measurement means, how to interpret a lipid panel in context, and how clinicians use risk calculators (ASCVD) to guide treatment. It includes real‑world examples, normal vs high values, and practical thresholds to inform shared decision‑making.
How to Read and Understand Your Lipid Panel
Step‑by‑step walkthrough of a standard lipid panel, sample reports, and clinician notes explaining each value and flags that require follow‑up.
LDL vs HDL vs Triglycerides: What Each Number Means for Your Heart
Explains physiological roles of LDL, HDL, and triglycerides, which levels are concerning, and how they differently affect cardiovascular risk.
When and How Often Should You Get Your Cholesterol Checked?
Guidance on screening intervals by age, risk factors, and treatment status, including fasting vs non‑fasting considerations.
How to Use the ASCVD Risk Calculator to Make Treatment Decisions
Explains inputs, thresholds, limitations, and how to use ASCVD risk scores in shared decision‑making with examples.
Familial Hypercholesterolemia: Recognize, Test, and Refer
Covers clinical features, diagnostic criteria, cascade screening, and urgency of aggressive treatment for FH.
2. Statin Therapy Essentials
Comprehensive, guideline‑aligned coverage of statin medications: mechanisms, evidence of benefit, indications, intensity schemes, monitoring, and side effect management. This is the clinical center of the site.
The Definitive Statin Therapy Guide: Indications, Dosing, Risks, and Monitoring
A definitive reference on statin therapy that synthesizes guidelines and trial evidence for when to start statins, which intensity to choose, how to monitor safety and effectiveness, and how to manage adverse effects. It equips clinicians and informed patients to make evidence‑based decisions.
Statin Types, Potency, and Choosing the Right Drug
Compare common statins (atorvastatin, rosuvastatin, simvastatin, pravastatin) by potency, half‑life, dosing, and practical selection tips.
How to Start, Titrate, and Switch Statins Safely
Stepwise protocols for initiating therapy, escalating intensity, switching agents for side effects or interactions, and documenting follow‑up plans.
Statin Side Effects: Myopathy, Liver Tests, Cognitive Concerns, and Management
Detailed look at frequency, diagnosis, and management of common and rare statin adverse effects, including guidance on rechallenge and alternative strategies.
Statin Drug Interactions and Safe Prescribing
Lists common interacting drugs, mechanisms (CYP3A4, OATP1B1), and practical prescribing adjustments to avoid harm.
Statins in Special Clinical Situations: Liver disease, Surgery, and Acute Illness
Guidance on continuing or pausing statins during acute illness, pre/post‑op, and in patients with stable chronic liver disease.
3. Non‑Statin and Combination Lipid‑Lowering Therapies
Explores evidence, indications, and practical use of non‑statin agents and combination therapy for patients who need additional LDL lowering or cannot tolerate statins.
Non‑Statin and Combination Lipid‑Lowering Therapies: When and How to Use Them
Covers ezetimibe, PCSK9 inhibitors, bempedoic acid, fibrates, omega‑3 fatty acids, and procedural options (LDL apheresis). Explains indications for escalation, expected LDL reductions, safety, cost/access issues, and algorithmic approaches.
PCSK9 Inhibitors: Mechanism, Evidence, Who Should Get Them, and Cost
Explains how PCSK9 inhibitors work, trial outcomes, eligibility (e.g., ASCVD with high LDL despite maximally tolerated statin), and practical access considerations.
Ezetimibe: Add‑on Therapy Explained
Clear, evidence‑based guidance on when to add ezetimibe, expected LDL reduction, and safety profile.
Bempedoic Acid and New Oral Agents: Uses and Evidence
Summarizes bempedoic acid's place in therapy, expected benefit, side effects, and trial data supporting use.
Fibrates, Omega‑3s, and Triglyceride Lowering: When They Help
Reviews evidence for fibrates and prescription omega‑3s in lowering triglycerides and reducing residual cardiovascular risk.
LDL Apheresis, Gene Therapy, and Emerging Treatments
Describes advanced and experimental options for severe, treatment‑resistant hypercholesterolemia and the research landscape.
4. Lifestyle, Diet, and Prevention
Practical, evidence‑based lifestyle interventions for lowering cholesterol and reducing heart disease risk — diet, exercise, weight loss, smoking cessation, and clinical use of supplements.
Lifestyle and Diet Strategies to Lower Cholesterol and Reduce Heart Disease Risk
Provides actionable, guideline‑based lifestyle recommendations (dietary patterns, exercise prescriptions, weight management) with expected magnitude of effect on lipid levels and cardiovascular risk, plus sample meal plans and counseling tips.
Mediterranean, Low‑Fat, and Plant‑Based Diets Compared for Cholesterol
Compares major dietary approaches, expected lipid changes, cardiovascular outcomes, and how to implement each in practice.
Exercise to Lower Cholesterol: What Works and How Much You Need
Provides an evidence‑based exercise prescription (aerobic, resistance) and describes the likely impact on HDL, LDL, and triglycerides.
Supplements and Over‑the‑Counter Options: Evidence and Safety
Evaluates red yeast rice, phytosterols, soluble fiber, niacin, and other supplements for effectiveness, purity concerns, and interactions with statins.
Weight Loss, Alcohol, and Smoking: Holistic Lifestyle Effects on Lipids
Explains how weight reduction, alcohol moderation, and smoking cessation affect lipid profiles and overall cardiovascular risk.
5. Special Populations and Complex Case Management
Focused guidance for populations requiring tailored approaches: pregnancy, pediatrics, elderly, diabetes, chronic kidney disease, and familial hypercholesterolemia. This group supports clinicians managing non‑standard scenarios.
Managing Cholesterol and Statins in Special Populations: Pregnancy, Children, Elderly, Diabetes, and Kidney Disease
Provides nuanced, evidence‑based recommendations and caveats for lipid management and statin use across special groups—what to avoid, when to refer, and how targets differ by condition.
Statins, Pregnancy, and Breastfeeding: Guidance for Patients and Clinicians
Clear guidance on contraception, stopping statins prior to conception, and postpartum management with references to guideline statements.
High Cholesterol in Children and Adolescents: Screening and Treatment
Covers when to screen children, lifestyle first approaches, and indications for pharmacotherapy including statins.
Diabetes and Lipids: Who Needs a Statin and What Targets to Aim For
Summarizes guideline recommendations for statin use in type 1 and type 2 diabetes and strategies for residual risk reduction.
Chronic Kidney Disease and Lipid Management
Explains how CKD alters risk calculations and how to approach statin therapy in nondialysis and dialysis patients.
Familial Hypercholesterolemia: Advanced Care Pathways and Referral Criteria
Detailed action checklist for clinicians on genetic testing, cascade screening, and aggressive multimodal therapy for FH patients.
6. Patient Journey, Adherence, and Shared Decision‑Making
Practical materials that help clinicians and patients discuss risks/benefits, improve adherence, manage side effects, navigate costs, and handle stopping or rechallenging therapy.
Patient's Guide to Starting, Staying on, and Stopping Statins: Conversations, Adherence, Costs, and Follow‑Up
A patient‑focused pillar that provides scripts, decision aids, monitoring schedules, and practical strategies to improve adherence and manage costs and side effects—designed for shared decision‑making.
How to Discuss Statin Risks and Benefits: Scripts and Decision Aids
Provides clinician scripts, patient handouts, and visual aids that explain absolute vs relative risk reduction and facilitate informed consent.
Improving Statin Adherence: Practical Strategies for Patients and Clinics
Evidence‑based interventions to boost long‑term adherence including reminders, simplification, side‑effect management, and team‑based care.
Managing Side Effects, Rechallenge, and Alternative Dosing Strategies
Detailed protocols for evaluating suspected statin adverse reactions, temporary discontinuation, and strategies for safe rechallenge or alternative regimens.
Cost, Insurance, and Financial Assistance for Cholesterol Medications
Practical guidance on generics vs brand names, prior authorization, patient assistance programs, and coding/billing tips to improve access.
How and When to Stop Statins: Deprescribing Considerations
Explains clinical situations where stopping may be appropriate, risks of abrupt cessation, and stepwise deprescribing with monitoring advice.
Content strategy and topical authority plan for Cholesterol and Statin Therapy Guide
The recommended SEO content strategy for Cholesterol and Statin Therapy Guide is the hub-and-spoke topical map model: one comprehensive pillar page on Cholesterol and Statin Therapy Guide, supported by 29 cluster articles each targeting a specific sub-topic. This gives Google the complete hub-and-spoke coverage it needs to rank your site as a topical authority on Cholesterol and Statin Therapy Guide.
35
Articles in plan
6
Content groups
22
High-priority articles
~6 months
Est. time to authority
Search intent coverage across Cholesterol and Statin Therapy Guide
This topical map covers the full intent mix needed to build authority, not just one article type.
Entities and concepts to cover in Cholesterol and Statin Therapy Guide
Publishing order
Start with the pillar page, then publish the 22 high-priority articles first to establish coverage around what do my cholesterol numbers mean faster.
Estimated time to authority: ~6 months